Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
Richard S P HuangLukas HarriesBrennan DeckerMatthew C HiemenzKarthikeyan MurugesanJames CreedenKhaled TolbaLaura P StabileShakti H RamkissoonTimothy F BurnsJeffrey S RossPublished in: The oncologist (2022)
Herein, we defined the clinicopathologic, genomic, and biomarker landscape of a large cohort of patients with NSCLC-BM which can help inform study design of future clinical studies for patients with NSCLC with BM. In certain clinical situations, metastatic NSCLC brain tissue or cerebral spinal fluid specimens may be needed to fully optimize personalized treatment.